Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Gastrointestinal 2Head & Neck 1Gynecologic 1

Conditions

Ovarian Neoplasms 508Uterine Cervical Neoplasms 361Endometrial Neoplasms 305Breast Neoplasms 130Colorectal Neoplasms 112Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 87Stomach Neoplasms 83Pancreatic Neoplasms 79Lung Neoplasms 72Melanoma 68Prostatic Neoplasms 67Carcinoma, Ovarian Epithelial 65Neoplasm Metastasis 63Triple Negative Breast Neoplasms 51Vulvar Neoplasms 50Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 43Uterine Neoplasms 40Peritoneal Neoplasms 40Urinary Bladder Neoplasms 38Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Uterine Cervical Dysplasia 31Sarcoma 31Papillomavirus Infections 31Colonic Neoplasms 31Recurrence 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Patient Satisfaction × Gynecologic × Clear all
NCT06459271 2025-12-16

Feasibility of CALM in Patients With Ovarian Cancer

University Health Network, Toronto

Phase NA Recruiting
50 enrolled
Gynecologic

Ovarian Neoplasms, Patient Satisfaction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡